These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 11808941)

  • 21. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
    Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
    Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
    Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
    Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
    Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Suwangool P; Mahachai V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S250-6. PubMed ID: 12929997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
    Haushofer AC; Hauer R; Brunner H; Köller U; Trubert-Exinger D; Halbmayer WM; Koidl C; Kessler HH
    J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of prognostic factors in hepatocellular carcinoma in Japan.
    Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
    Aliment Pharmacol Ther; 2010 Feb; 31(3):407-14. PubMed ID: 19849688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
    Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
    Ohba K; Kubo S; Tamori A; Hirohashi K; Tanaka H; Shuto T; Nishiguchi S; Kinoshita H
    Surg Today; 2004; 34(10):842-8. PubMed ID: 15449154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.